Therapeutic augmentation of ketogenic diet with a sodium-glucose cotransporter 2 inhibitor in a super-refractory status epilepticus patient

BACKGROUND: A ketogenic diet (KD) may have a role in treating patients in super-refractory status epilepticus (SRSE). Sodium-glucose cotransporter 2 (SGLT2) inhibitors have a risk of ketoacidosis that could facilitate induction of KD. CASE SUMMARY: A 42-year-old with a history of drug resistant epil...

Descripción completa

Detalles Bibliográficos
Autores principales: Blunck, Joseph R., Newman, Joseph W., Fields, Ronald K., Croom, John E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068319/
https://www.ncbi.nlm.nih.gov/pubmed/30073144
http://dx.doi.org/10.1016/j.ebcr.2018.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068319/
https://www.ncbi.nlm.nih.gov/pubmed/30073144
http://dx.doi.org/10.1016/j.ebcr.2018.05.002

Ejemplares similares